Prostate cancer decisions — 2024

The Veteran's appeal for an initial compensable disability rating for hypertension is dismissed. The Board has remanded the issues of service connection for coronary artery disease, prostate cancer, and type II diabetes mellitus.

The Veteran's prostate cancer is presumed to be related to herbicide agent exposure during his service in Thailand, and the Board has granted service connection for this condition.

The Board has decided to remand the Veteran's claim for service connection of prostate cancer due to insufficient medical opinions regarding causation and aggravation.

The Veteran's prostate cancer is presumed to be related to exposure to herbicide agents, but the AOJ did not verify his exposure during service. The Board finds additional development necessary, including obtaining community care records and verifying exposure.

The Veteran's prostate cancer is rated at the maximum schedular rating of 40 percent, and there is no evidence of renal dysfunction or obstructed voiding. The Veteran does not have physical deformity of his penis for a compensable rating for erectile dysfunction.,A surgical scar from prostatectomy has an area less than 39 square centimeters and does not meet the criteria for any higher rating under Diagnostic Codes 7801, 7802, or 7804.

The Board has remanded the case due to an inextricably intertwined issue of service connection for prostate cancer, and a decision on lymphedema as secondary to prostate cancer cannot be made without first resolving this issue.

The Veteran's prostate cancer and erectile dysfunction are granted as service-connected.,The Veteran's hypertension, gout (bilateral heel), heart conditions, renal cell carcinoma, and gastroesophageal reflux disease (GERD) are remanded for further review.

The Board has restored service connection for carotid artery stenosis, prostate cancer, diabetes mellitus (DM II), and erectile dysfunction (ED). Additionally, the entitlement to special monthly compensation based on loss of use of a creative organ and housebound status have been reinstated. The appeal was not about exposure to Agent Orange or any other presumptive conditions.

The Veteran's service-connected disabilities have prevented him from securing or following a substantially gainful occupation, and the Board has granted TDIU.

The Veteran's appeal for service connection for an acquired psychiatric disorder and colitis is dismissed as moot.,Service connection for a right knee disorder, left knee disorder, and back disorder are denied.

The Veteran's appeal for an increased disability rating in excess of 60 percent for prostate cancer with urinary dysfunction is dismissed as withdrawn.

The Veteran's prostate cancer is granted as service-connected due to presumptive Agent Orange exposure during his Navy service.,The Veteran's thyroid cancer is granted as service-connected due to toxic exposure from dry cleaning chemicals in active Naval service.

The Veteran's entitlement to service connection for internal or external hemorrhoids status post hemorrhoidectomy with residuals is granted. The Veteran's entitlement to a disability rating of 40 percent, and no higher, for residual(s) of prostate cancer from May 14, 2024, is granted.

The Veteran's appeal to reduce his prostate cancer disability rating from 100% to 60% was dismissed because the proposed reduction was not a final decision and the Veteran did not file a Notice of Disagreement within one year.

The Veteran's bilateral hearing loss claim is denied as the evidence does not support a compensable evaluation.,Ischemic heart disease and prostate cancer claims are remanded due to insufficient verification of exposure to herbicide agents.

The Veteran's cause of death was granted service connection, and the surviving spouse (Appellant) has already been awarded Dependency and Indemnity Compensation (DIC) benefits. The appeal is dismissed as there are no live issues or claims remaining.

The Veteran was granted a total disability rating based on individual unemployability (TDIU) due to his service-connected PTSD and prostate cancer residuals, which rendered him unable to secure or follow a substantially gainful occupation.

The Veteran's prostate cancer residuals and coronary artery disease were granted increased evaluations, effective June 20, 2023. The appeal for attorney fees based on these past-due benefits is denied.

The Veteran's prostate cancer with voiding dysfunction residuals is rated at 40 percent disabling, effective September 1, 2008. The rating was decreased to 20 percent effective May 24, 2023.

The Veteran's prostate cancer with voiding dysfunction residuals is rated at 40 percent disabling, effective September 1, 2008. The rating was decreased to 20 percent effective May 24, 2023.